Cervical cancer ovarian cancer endometrial cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 : In line with cervical cancer ovarian cancer endometrial cancer in any diagnostic criteria confirmed by histopathology FIGO stage I ~ III patients with TC regimen chemotherapy 2 : The treatment plan is surgery + chemotherapy including neoadjuvant chemotherapy postoperative chemotherapy etc. without limiting the surgical procedure. 3 : in line with the diagnosis of traditional Chinese medicine and syndrome differentiation belongs to qi and blood deficiency type 4 : In line with the diagnostic criteria of bone marrow suppression according to the WHO bone marrow suppression classification in grade I-II. 5 : aged between 30 to 75 years old and expected survival = 3 months. 6 : KPS score = 60 points 7 : Bone marrow liver and kidney function were normal before intervention. 8 : Can be clearly expressed volunteered to participate in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1 : Patients with malignant tumors of other systems or organs 2 : Combined with basic blood diseases severe infection respiratory insufficiency acute and chronic heart failure gastrointestinal bleeding jaundice severe hypertension chronic kidney disease stage 2 ~ 5 acute cerebrovascular disease and other serious heart brain liver lung kidney and other serious organ damage. 3 : Synchronous use of radiotherapy and other therapies 4 : For the application material and contains the relevant Chinese medicine ingredients have a history of allergy 5 : Skin ulceration at the application site 6 : Patients with mental illness 7 : Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| chinese medicine syndrome scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bone marrow suppression;The use of blood cell drugs;cytometry; | — |
Countries
China
Contacts
The Peoples Hospital Affiliated to Fujian University of Traditional Chinese Medicine